HomeAI · summaries
Storia in 2 fonti
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chain
Niti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think tank urges a shift towards high-value segments, emphasizing enhanced industry-academia collaboration for patent commercialization and startup incubation. While India is the 'pharmacy of the world,' it needs to move up the value chain by focusing on deeptech innovation to become a capital for pharma innovation.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI Aayog
India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearly 65% of APIs and intermediates sourced…
- ·
thehindubusinessline.com
India's pharma supply chain heavily dependent on Chinese imports: NITI Aayog
